First Time Loading...

Zhejiang Huahai Pharmaceutical Co Ltd
SSE:600521

Watchlist Manager
Zhejiang Huahai Pharmaceutical Co Ltd Logo
Zhejiang Huahai Pharmaceutical Co Ltd
SSE:600521
Watchlist
Price: 17.79 CNY 1.83% Market Closed
Updated: May 7, 2024

Wall Street
Price Targets

Price Targets Summary
Zhejiang Huahai Pharmaceutical Co Ltd

Wall Street analysts forecast Zhejiang Huahai Pharmaceutical Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhejiang Huahai Pharmaceutical Co Ltd is 16.69 CNY with a low forecast of 14.14 CNY and a high forecast of 20.48 CNY.

Lowest
Price Target
14.14 CNY
21% Downside
Average
Price Target
16.69 CNY
6% Downside
Highest
Price Target
20.48 CNY
15% Upside
Zhejiang Huahai Pharmaceutical Co Ltd Competitors:
Price Targets
MEGA
Mega Lifesciences PCL
24% Upside
002603
Shijiazhuang Yiling Pharmaceutical Co Ltd
46% Upside
ATAI
ATAI Life Sciences NV
414% Upside
TSPC
Tempo Scan Pacific Tbk PT
15% Downside
OFSA3
Ouro Fino Saude Animal Participacoes SA
10% Upside
CGTX
Cognition Therapeutics Inc
286% Upside
SANOFI
Sanofi India Ltd
12% Upside
3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd
62% Upside

Revenue
Forecast

Revenue Estimate
Zhejiang Huahai Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang Huahai Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 10%.

16%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zhejiang Huahai Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang Huahai Pharmaceutical Co Ltd's operating income is 22%. The projected CAGR for the next 3 years is 4%.

22%
Past Growth
4%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Zhejiang Huahai Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang Huahai Pharmaceutical Co Ltd's net income is 20%. The projected CAGR for the next 3 years is 4%.

20%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhejiang Huahai Pharmaceutical Co Ltd's stock price target?
Price Target
16.69 CNY

According to Wall Street analysts, the average 1-year price target for Zhejiang Huahai Pharmaceutical Co Ltd is 16.69 CNY with a low forecast of 14.14 CNY and a high forecast of 20.48 CNY.

What is Zhejiang Huahai Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Zhejiang Huahai Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 10%.

What is Zhejiang Huahai Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Zhejiang Huahai Pharmaceutical Co Ltd's operating income is 22%. The projected CAGR for the next 3 years is 4%.

What is Zhejiang Huahai Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Zhejiang Huahai Pharmaceutical Co Ltd's net income is 20%. The projected CAGR for the next 3 years is 4%.